10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-003345`
Period End Date	20191231
Filing Date	20200205
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	tyme-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 54 Cash Flow Statement 47 Stockholders Equity 39

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$470.84K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$592.13K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$293.80K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.00M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.48K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.36K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$101.15K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$229.48K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$447.90K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total assets	`Assets`	$17.52M	USD	Point-in-time
Total assets	`Assets`	$13.73M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	112.53M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	103.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	112.53M	shares	Point-in-time
Accounts payable and other current liabilities (including $222,000 and $325,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.54M	USD	Point-in-time
Accounts payable and other current liabilities (including $222,000 and $325,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.69M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$375.07K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$428.24K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.30M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.50M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$597.34K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$58.89K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.21M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.36M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.64M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$10.16K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$4.69M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.33M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 112,533,905 issued and outstanding at December 31, 2019, 300,000,000 authorized, 103,946,048 issued and outstanding at March 31, 2019	`CommonStockValue`	$10.40K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 112,533,905 issued and outstanding at December 31, 2019, 300,000,000 authorized, 103,946,048 issued and outstanding at March 31, 2019	`CommonStockValue`	$11.26K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$95.47M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$104.48M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-102.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.81M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.77M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.52M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.73M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$132.00K	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$58.50K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$307.00K	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$794.00K	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.45M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.29M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.98M	USD	3 Qtrs
General and administrative (including $58,500, $132,000, $307,000 and $794,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.55M	USD	1 Quarter
General and administrative (including $58,500, $132,000, $307,000 and $794,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$10.83M	USD	3 Qtrs
General and administrative (including $58,500, $132,000, $307,000 and $794,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$9.67M	USD	3 Qtrs
General and administrative (including $58,500, $132,000, $307,000 and $794,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.09M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.08M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.54M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$21.81M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$18.97M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-8.08M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-21.81M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.54M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-18.97M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$425.80K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.59M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$28.72K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$185.75K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$38.26K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$28.72K	USD	3 Qtrs
Interest expense	`InterestExpense`	$7.28K	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.22K	USD	1 Quarter
Interest expense	`InterestExpense`	$26.31K	USD	1 Quarter
Interest expense	`InterestExpense`	$88.53K	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-413.85K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$2.69M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$21.44K	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$27.50K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.96M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.28M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.96M	shares	3 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.96M	shares	3 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	103.01M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	112.07M	shares	1 Quarter

Cash Flow Statement 47 line items

Line Item	Tag	Value	Unit	Period
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	301,959.00	shares	3 Qtrs
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	78,431.00	shares	3 Qtrs
Net loss	`ProfitLoss`	$-16.28M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-21.79M	USD	3 Qtrs
Cashless exercise of shares of common stock	`CashlessExerciseOfSharesOfCommonStock`	4,889.00	shares	3 Qtrs
Cashless exercise of shares of common stock	`CashlessExerciseOfSharesOfCommonStock`	84,034.00	shares	3 Qtrs
Depreciation	`Depreciation`	$3.89K	USD	3 Qtrs
Depreciation	`Depreciation`	$7.11K	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$6.70M	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$4.67M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$425.80K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.59M	USD	3 Qtrs
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$404.59K	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-121.30K	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$470.15K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-445.83K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-708.10K	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-218.42K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-521.84K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-157.04K	USD	3 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-330.47K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-193.89K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-80.90K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-34.94K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.11M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.86M	USD	3 Qtrs
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	3 Qtrs
Insurance note payments	`InsuranceNotePayments`	$441.08K	USD	3 Qtrs
Insurance note payments	`InsuranceNotePayments`	$597.34K	USD	3 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$4.05M	USD	3 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$11.62M	USD	3 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$270.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.02M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.88M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.84M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-12.24M	USD	3 Qtrs
Cash and cash equivalents beginning	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents beginning	`CashAndCashEquivalentsAtCarryingValue`	$16.73M	USD	Point-in-time
Cash and cash equivalents beginning	`CashAndCashEquivalentsAtCarryingValue`	$11.47M	USD	Point-in-time
Cash and cash equivalents beginning	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents ending	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents ending	`CashAndCashEquivalentsAtCarryingValue`	$16.73M	USD	Point-in-time
Cash and cash equivalents ending	`CashAndCashEquivalentsAtCarryingValue`	$11.47M	USD	Point-in-time
Cash and cash equivalents ending	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Interest	`InterestPaidNet`	$88.53K	USD	3 Qtrs
Interest	`InterestPaidNet`	$7.28K	USD	3 Qtrs

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$20.77M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.71M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$2.40M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$22.27M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	112.53M	shares	Point-in-time
Issuance of common stock from underwritten registered offering, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$452.55K	USD	1 Quarter
Issuance of common stock from underwritten registered offering, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$3.89M	USD	1 Quarter
Issuance of common stock from underwritten registered offering, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$3.34M	USD	1 Quarter
Issuance of common stock from underwritten registered offering, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$714.27K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$270.00K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.52M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.62M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.60M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.18M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.00M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.45M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.96M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.28M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$20.77M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.71M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$2.40M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$22.27M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	112.53M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.